Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Audit of Genzyme Transgenics' rhATIII production facility triggers milestone

Jan. 13, 1998

Roberts seeks to broaden market for Agrylin

Jan. 13, 1998

Cell adhesion inhibitors from Merck KGaA

Jan. 12, 1998

Thrombin inhibitors reported by BMS

Jan. 9, 1998

Vasoflux preclinical data presented at major hematology congress

Jan. 8, 1998

Efficacy of recombinant hirudin demonstrated in patients with DIC

Jan. 8, 1998

Antiplatelet effects of policosanol, aspirin and policosanol + aspirin in humans

Jan. 5, 1998

New anticoagulants reported by Berlex

Jan. 2, 1998

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

Improved method for vWF purification developed by Bayer

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...